Evidence map›Paper›PMID 36969300›Full record

ArticleJournal of kidney cancer and VHL2023

Mayo Adhesive Probability Score Does Not Have Prognostic Ability in Locally Advanced Renal Cell Carcinoma.

Benjamin N Schmeusser, Tad A Manalo, Yuan Liu, Yash B Shah, Adil Ali, Manuel Armas-Phan, Dattatraya H Patil, Reza Nabavizadeh, Kenneth Ogan, Viraj A Master

Full text read
In one paragraph

Article in Journal of kidney cancer and VHL, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Benjamin N SchmeusserDepartment of Urology, Emory University School of Medicine, Atlanta, GA, USA.
Tad A ManaloDepartment of Urology, University of Colorado School of Medicine, Denver, CO, USA.
Yuan LiuDepartment of Biostatistics and Bioinformatics, Emory University School of Medicine, Atlanta, GA, USA.
Yash B ShahSidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
Adil AliDepartment of Urology, Emory University School of Medicine, Atlanta, GA, USA.
Manuel Armas-PhanDepartment of Urology, Emory University School of Medicine, Atlanta, GA, USA.
Dattatraya H PatilDepartment of Urology, Emory University School of Medicine, Atlanta, GA, USA.
Reza NabavizadehDepartment of Urology, Emory University School of Medicine, Atlanta, GA, USA.
Kenneth OganDepartment of Urology, Emory University School of Medicine, Atlanta, GA, USA.
Viraj A MasterDepartment of Urology, Emory University School of Medicine, Atlanta, GA, USA.

Funding

Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · 2009 to 2026
$47.5M
NCI NIH HHS P30 CA138292
6 · The paper itself

Abstract

Nephrectomy remains standard treatment for renal cell carcinoma (RCC). The Mayo Adhesive Probability (MAP) score is predictive of adherent perinephric fat and associated surgical complexity, and is determined by assessing perinephric fat and stranding. MAP has additionally predicted progression-free survival (PFS), though primarily reported in stage T1-T2 RCC. Here, we examine MAP's ability to predict overall survival (OS) and PFS in T3-T4 RCC. From our prospectively maintained RCC database, patients that underwent radical nephrectomy (2009-2016) with available abdominal imaging (<90 days preop) and T3/T4 RCC underwent MAP scoring. Survival analyses were conducted with MAP scores as individual (0-5) and dichotomized (0-3 vs 4-5) using Kaplan-Meier method. Multivariable Cox proportional hazard regression models for PFS and OS were built with backward elimination. 141 patients were included. 134 (95%) and 7 (5%) had pT3 and pT4 disease, respectively. 46.1% of patients had an inferior vena cava thrombus. Mean MAP score was 3.22±1.52, with 75 (53%) patients having a score between 0-3 and 66 (47%) having a score of 4-5. Both male gender (p=0.006) and clear cell histology (p=0.012) were associated with increased MAP scores. On Kaplan-Meier and multivariable analysis, no significant associations were identified between MAP and PFS (HR=1.01, 95% CI 0.85-1.20, p=0.93) or OS (HR=1.01, 95% CI 0.84-1.21, p=0.917). In this cohort of patients with locally advanced RCC, high MAP scores were not predictive of worse PFS or OS.

Indexed as

body compositionkidney cancermayo adhesive probabilityrenal cell carcinomasurvival

Identifiers

PMID36969300
PMCPMC10036918

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read19
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.